Recombinant CD3E (Foralumab Biosimilar) anticorps

N° du produit ABIN7795098

L’anticorps anti-CD3E (Foralumab Biosimilar) Monoclonal Humanized est utilisé pour la détection de CD3E (Foralumab Biosimilar) dans des échantillons de Humain. Il a été validé pour FACS et in vivo.

Aperçu rapide pour Recombinant CD3E (Foralumab Biosimilar) anticorps (ABIN7795098)

Antigène: CD3E (Foralumab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Humanized

Clonalité: Monoclonal

Conjugué: Cet anticorp CD3E (Foralumab Biosimilar) est non-conjugé

Application: Flow Cytometry (FACS), In vivo Studies (in vivo)

Classe de qualité: Research Grade

Détail du produit anti-CD3E (Foralumab Biosimilar) anticorps

Expression System: Mammalian cells

Fonction: Foralumab Biosimilar, Human CD3e Monoclonal Antibody

Attributs du produit: Foralumab Biosimilar uses the same protein sequences as the therapeutic antibody foralumab (humanized OKT3). A fully human monoclonal antibody that binds to CD3 epsilon of the T cell receptor-CD3 complex, Foralumab (humanized OKT-3) is used as immunosuppressive therapy in kidney, heart, and liver transplant patients.

Purification: Protein A or G affinity column

Pureté: >95 % by reducing SDS-PAGE

niveau d'endotoxine: < 1 EU per 1 mg of the protein by the LAL method

Immunogène: Human CD3e

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: > 3 mg/mL

Stock: 4 °C,-20 °C

Stockage commentaire: Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.

Détails sur CD3E (Foralumab Biosimilar)

Antigène: CD3E (Foralumab Biosimilar)

Autre désignation: Foralumab Biosimilar

Classe de substances: Biosimilar